# Maternal-Fetal Medicine Referral

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Charlotte Brontë (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI025-SYN
- Date: 2026-01-13
- Fictional facility: St. Posthumous Health Center
- Fictional author: Eleanor Thwaite, MD
- Calendar frame: modern shifted

- To: Margaret Oyelaran-Hughes, MD, Maternal-Fetal Medicine
- Urgency: Soon, within one to two weeks; same-day review here if she cannot keep fluids down

## Referral question

First pregnancy at 38, at 7 weeks 1 day by today's dating scan, with moderate nausea and vomiting for a week and early weight loss. Please advise on the plan if it worsens, on aneuploidy screening and diagnostic options at her age, on preeclampsia prevention, and on her tuberculosis risk. **S**

## Questions for the consultant

1. What escalation plan do you advise if her nausea and vomiting worsens, including the thresholds for intravenous fluids or admission and the place of ondansetron before 10 weeks?
2. What aneuploidy screening and diagnostic options should we offer at 38, and when?
3. Does she need low-dose aspirin for preeclampsia prevention, and from when?
4. How should we interpret and act on her family history of tuberculosis in pregnancy?
5. What else should the plan for the rest of this pregnancy include because of her age?

## Pertinent history

Ms. Brontë is a 38-year-old novelist, married seven months, in a planned first pregnancy with a single live intrauterine pregnancy measuring 7 weeks 1 day. Nausea most of the day and vomiting three or four times a day began a week ago; PUQE-24 score 10 (moderate). She weighs 45.1 kg, 2 percent below her pre-pregnancy 46.0 kg (height 152 cm). Blood pressure 104/66 mmHg, pulse 84. Sodium 137, potassium 3.9 mmol/L, creatinine 0.52 mg/dL, hemoglobin 12.8 g/dL; urine ketones 15 mg/dL. She starts doxylamine-pyridoxine two tablets at bedtime today, with folic acid in place of her iron-containing prenatal vitamin. Her mother died young after a long illness, two elder sisters died of tuberculosis in childhood, and two more sisters died of tuberculosis as young adults, in her household; an interferon-gamma release assay was sent today with the first prenatal tests. PHQ-9 5. She received the influenza vaccine today. No medical history of note and no allergies. **S**

- Charlotte Brontë was born on 21 April 1816 in Thornton, Yorkshire, the third of six children of Maria Branwell and her husband, an Anglican clergyman. **D**
- Jane Eyre was first published in 1847 under the pseudonym Currer Bell. **D**
- Her mother died on 15 September 1821, in the 39th year of her age, after a long and painful illness. **D**
- Her mother's illness may have been cancer; one reference work says uterine cancer. The cause is a later interpretation. **R**
- Her two elder sisters, Maria and Elizabeth, fell ill at the Clergy Daughters' School at Cowan Bridge and died at home in 1825, Maria on 6 May aged 11 and Elizabeth on 15 June aged 10; reference works give tuberculosis. **D**
- Her brother Branwell died on 24 September 1848, aged 31, of several conditions made worse by heavy drinking; tuberculosis is listed among them. **D**
- Her sisters Emily and Anne died of tuberculosis, Emily on 19 December 1848 aged 30 and Anne on 28 May 1849 aged 29. **D**
- On 29 June 1854 she married Arthur Bell Nicholls, her father's curate, at Haworth. **D**
- In late November 1854, after a long walk on the moors to a waterfall that ended in heavy rain, she began to shiver and had a bad lingering sore throat and cold that made her thin and weak. **D**
- Early in 1855, after a visit to Gawthorpe and a long walk over damp ground in thin shoes, she was attacked by "new sensations of perpetual nausea, and ever-recurring faintness"; a doctor who was called assigned a natural cause for her indisposition. **D**

10 later historical claims are omitted because they describe events after the index age. See the teaching note.

Baseline: Hemoglobin: 12.8 g/dL; White blood cells: 8.4 10*3/uL; Platelets: 248 10*3/uL; Sodium: 137 mmol/L; Potassium: 3.9 mmol/L; Chloride: 102 mmol/L; Bicarbonate (total CO2): 24 mmol/L; BUN: 8 mg/dL; Creatinine: 0.52 mg/dL; Glucose: 76 mg/dL; Urine ketones: 15 mg/dL (high); Crown-rump length: 11 mm; PHQ-9: 5. All results are synthetic.

BP 104/66 mmHg; pulse 84 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 99% on room air; weight 45.1 kg; BMI 19.5 kg/m². All vital signs are synthetic.

## Current medications

- Folic acid 0.4 mg oral tablet, one tablet by mouth daily (replacing an iron-containing prenatal vitamin while nausea is severe) **S**
- Doxylamine 10 mg and pyridoxine 10 mg delayed-release tablet, two tablets by mouth at bedtime **S**

## Plan so far

- First prenatal visit: dating ultrasound; blood count, blood group and antibody screen, rubella immunity, hepatitis B surface antigen, HIV, syphilis, and hepatitis C tests; urine culture; metabolic panel and urinalysis because of vomiting; influenza vaccine; folic acid 0.4 mg daily in place of the iron-containing prenatal vitamin while nausea lasts. Guideline: USPSTF A and B Recommendations (2026); Guidelines for Vaccinating Pregnant Persons (2026) **S**
- Nausea and vomiting, step by step: small frequent dry meals, fluids between meals, ginger if she wishes, and avoiding smells that trigger nausea; doxylamine-pyridoxine from today, raised to four tablets a day if needed; then a second drug (metoclopramide, promethazine, or ondansetron after counseling); PUQE-24 score, weight, pulse, blood pressure, and electrolytes at each visit; same-day review if she cannot keep fluids down for 24 hours or loses more than 5 percent of her pre-pregnancy weight. Guideline: ACOG Practice Bulletin No. 189: Nausea and Vomiting of Pregnancy (2018); The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69) (2024) **S**
- Aneuploidy screening offered to all, with diagnostic testing available: cell-free DNA from 10 weeks, a nuchal translucency scan at 11 to 14 weeks, or chorionic villus sampling or amniocentesis; a detailed anatomy scan at 18 to 22 weeks. Guideline: Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226 (2020) **S**
- Tuberculosis screening with an interferon-gamma release assay because of tuberculosis deaths in her household; a shielded chest radiograph and treatment decisions only if it is positive. Guideline: Latent Tuberculosis Infection in Adults: Screening (2023) **S**
- Mental health: PHQ-9 at intake and the EPDS in each trimester and after any admission, with support for the strain of severe vomiting and for anxiety rooted in family loss. Guideline: Screening and Diagnosis of Mental Health Conditions During Pregnancy and Postpartum (Clinical Practice Guideline No. 4) (2023); Perinatal Depression: Preventive Interventions (2019) **S**
- Preeclampsia prevention: low-dose aspirin 81 mg at bedtime from 12 to 16 weeks until delivery if she has one high-risk or more than one moderate-risk factor (she has two: first pregnancy and age 35 or older); blood pressure at every visit. Guideline: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication (2021) **S**
- Monitoring while nausea and vomiting last: PUQE-24, weight, pulse, and blood pressure at every visit; electrolytes until stable on oral intake; liver tests if abnormal; mood each trimester; antiemetic side effects (drowsiness, restlessness or abnormal movements, constipation, palpitations). Guideline: ACOG Practice Bulletin No. 189: Nausea and Vomiting of Pregnancy (2018); The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69) (2024) **S**
